- Home
- CRDF vs BW Comparison
CRDF vs BW Comparison
Compare CRDF & BW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- BW
- Stock Information
- Founded
- CRDF 1999
- BW 1867
- Country
- CRDF United States
- BW United States
- Employees
- CRDF N/A
- BW N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- BW Building Products
- Sector
- CRDF Health Care
- BW Industrials
- Exchange
- CRDF Nasdaq
- BW Nasdaq
- Market Cap
- CRDF 144.4M
- BW 119.1M
- IPO Year
- CRDF N/A
- BW N/A
- Fundamental
- Price
- CRDF $2.20
- BW $3.13
- Analyst Decision
- CRDF Strong Buy
- BW Strong Buy
- Analyst Count
- CRDF 5
- BW 1
- Target Price
- CRDF $11.10
- BW $5.00
- AVG Volume (30 Days)
- CRDF 762.3K
- BW 3.4M
- Earning Date
- CRDF 11-06-2025
- BW 11-11-2025
- Dividend Yield
- CRDF N/A
- BW N/A
- EPS Growth
- CRDF N/A
- BW N/A
- EPS
- CRDF N/A
- BW N/A
- Revenue
- CRDF $545,000.00
- BW $724,905,000.00
- Revenue This Year
- CRDF N/A
- BW N/A
- Revenue Next Year
- CRDF N/A
- BW $8.02
- P/E Ratio
- CRDF N/A
- BW N/A
- Revenue Growth
- CRDF N/A
- BW 48.90
- 52 Week Low
- CRDF $1.90
- BW $0.22
- 52 Week High
- CRDF $5.64
- BW $3.55
- Technical
- Relative Strength Index (RSI)
- CRDF 52.58
- BW 59.02
- Support Level
- CRDF $1.99
- BW $2.70
- Resistance Level
- CRDF $2.13
- BW $3.31
- Average True Range (ATR)
- CRDF 0.10
- BW 0.34
- MACD
- CRDF 0.04
- BW -0.07
- Stochastic Oscillator
- CRDF 78.69
- BW 53.30
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About BW Babcock & Wilcox Enterprises Inc.
Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.